Prestige Consumer Healthcare (FRA:PBV) Long-Term Capital Lease Obligation : €7 Mil (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Prestige Consumer Healthcare Long-Term Capital Lease Obligation?

Prestige Consumer Healthcare's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €7 Mil.

Prestige Consumer Healthcare's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (€6 Mil) to Dec. 2023 (€6 Mil) but then increased from Dec. 2023 (€6 Mil) to Mar. 2024 (€7 Mil).

Prestige Consumer Healthcare's annual Long-Term Capital Lease Obligation declined from Mar. 2022 (€19 Mil) to Mar. 2023 (€11 Mil) and declined from Mar. 2023 (€11 Mil) to Mar. 2024 (€7 Mil).

Prestige Consumer Healthcare Long-Term Capital Lease Obligation Historical Data

The historical data trend for Prestige Consumer Healthcare's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prestige Consumer Healthcare Long-Term Capital Lease Obligation Chart

Prestige Consumer Healthcare Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

26.70

22.28

18.70

10.78

7.08

Prestige Consumer Healthcare Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															10.78	8.46	6.43	5.81	7.08

Prestige Consumer Healthcare (FRA:PBV) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Prestige Consumer Healthcare Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Prestige Consumer Healthcare's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Prestige Consumer Healthcare (FRA:PBV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Prestige Consumer Healthcare Inc (FRA:PBV) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

PBH:USA

Address

660 White Plains Road, Tarrytown, NY, USA, 10591

Website

https://www.prestigebrands.com

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Prestige Consumer Healthcare (FRA:PBV) Headlines

No Headlines